Ardelyx, Inc.
ARDX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001437402
In the last 90 days, Ardelyx, Inc. insiders filed 0 open-market purchases and 9 sales; 250 institutions reported holding it in 13F filings for Q2 2026, worth $906.4M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Ardelyx, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 203
- +8 vs. Q2 2024
- Shares held
- 142.7M
- +16.0M (+12.6%) vs. Q2 2024
- Total value
- $982.8M
- +$44.1M (+4.7%) vs. Q2 2024
- New holders
- 30
- 76 more added
- Sold out
- 22
- 66 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 250 | $906.4M |
| Q1 2026 | 242 | $1.01B |
| Q4 2025 | 229 | $972.9M |
| Q3 2025 | 223 | $891.4M |
| Q2 2025 | 206 | $657.3M |
| Q1 2025 | 221 | $808.7M |
| Q4 2024 | 213 | $765.2M |
| Q3 2024 | 203 | $982.8M |
| Q2 2024 | 197 | $1.07B |
| Q1 2024 | 189 | $1.03B |
| Q4 2023 | 161 | $849.0M |
| Q3 2023 | 150 | $513.5M |
| Q2 2023 | 146 | $426.0M |
| Q1 2023 | 130 | $550.1M |
| Q4 2022 | 104 | $225.7M |
| Q3 2022 | 83 | $79.6M |
| Q2 2022 | 78 | $22.7M |
| Q1 2022 | 89 | $42.4M |
| Q4 2021 | 100 | $46.0M |
| Q3 2021 | 108 | $66.7M |
| Q2 2021 | 127 | $643.2M |
| Q1 2021 | 125 | $559.7M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Ardelyx, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| GeoWealth Management, LLC | 39 | $269 | 0.00% | +39 | New |
| Farther Finance Advisors, LLC | 13 | $90 | 0.00% | +3+30.0% | Added |
| Bessemer Group Inc | 15 | $0 | 0.00% | +15 | New |
| Castleark Management LLC | 0 | $0 | 0.00% | −246,440−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −245,932−100.0% | Sold out |
| Monograph Wealth Advisors, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −38,007−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −34,971−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −33,000−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −32,375−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −23,421−100.0% | Sold out |
| World Equity Group, Inc. | 0 | $0 | 0.00% | −18,402−100.0% | Sold out |
| Good Life Advisors, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −13,933−100.0% | Sold out |
| Prospera Financial Services Inc | 0 | $0 | 0.00% | −13,542−100.0% | Sold out |
| Calamos Advisors LLC | 0 | $0 | 0.00% | −12,850−100.0% | Sold out |
| Coastal Bridge Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Redwood Wealth Management Group, LLC | 0 | $0 | 0.00% | −8,350−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −8,000−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −3,656−100.0% | Sold out |
| Anchor Investment Management, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −179−100.0% | Sold out |
| Bell Investment Advisors, Inc | 0 | $0 | 0.00% | −59−100.0% | Sold out |
| ZRC Wealth Management, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Benjamin F. Edwards & Company, Inc. | – | – | – | – | Not filed |